[Polymorphism in HLA and KIR genes and the impact on hematopoietic stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

Bull Cancer. 2016 Nov;103(11S):S243-S247. doi: 10.1016/j.bulcan.2016.09.005. Epub 2016 Nov 14.
[Article in French]

Abstract

In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the country with the purpose of offering careful analysis of published studies on clinical practice issues that remain to be disputed. This article addresses the impact of HLA and KIR gene polymorphism on the outcome of the transplantation in order to optimize unrelated donor selection.

Keywords: Greffe de CSH; Gènes HLA; Gènes KIR; HLA genes; HSCT; Incompatibilités permissives/non permissives; KIR genes; Overall survival; Permissive/non permissive incompatibilities; Survie globale.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Alleles
  • Donor Selection / standards*
  • France
  • Genotype
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility / genetics*
  • Histocompatibility / immunology
  • Histocompatibility Antigens / genetics*
  • Histocompatibility Antigens / immunology
  • Humans
  • Polymorphism, Genetic*
  • Receptors, KIR / genetics*
  • Receptors, KIR / immunology
  • Societies, Medical
  • Treatment Outcome

Substances

  • Histocompatibility Antigens
  • Receptors, KIR